HFWA(HFWA)
HFWA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $342M | $371M |
| Low | $340M | $369M |
| High | $346M | $373M |
| EBITDA Avg | $101M | $110M |
| Low | $101M | $109M |
| High | $103M | $111M |
| EBIT Avg | $103M | $112M |
| Low | $103M | $111M |
| High | $105M | $113M |
| Net Income Avg | $71M | $97M |
| Low | $68M | $93M |
| High | $74M | $101M |
| EPS Avg | $2.06 | $2.79 |
| Low | $1.98 | $2.70 |
| High | $2.15 | $2.94 |
| Analysts (Rev / EPS) | 4 / 5 | 4 / 5 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $86M | $88M | $90M | $89M | $92M | $94M | $95M |
| Low | $85M | $87M | $89M | $88M | $91M | $93M | $94M |
| High | $88M | $89M | $91M | $91M | $93M | $96M | $97M |
| EBITDA Avg | $26M | $26M | $27M | $26M | $27M | $28M | $28M |
| Low | $25M | $26M | $26M | $26M | $27M | $28M | $28M |
| High | $26M | $27M | $27M | $27M | $28M | $28M | $29M |
| EBIT Avg | $26M | $27M | $27M | $27M | $28M | $28M | $29M |
| Low | $26M | $26M | $27M | $27M | $27M | $28M | $29M |
| High | $27M | $27M | $28M | $27M | $28M | $29M | $29M |
| Net Income Avg | $17M | $19M | $25M | $25M | $27M | $28M | $29M |
| Low | $16M | $18M | $24M | $25M | $26M | $28M | $29M |
| High | $19M | $20M | $25M | $26M | $27M | $29M | $30M |
| EPS Avg | $0.45 | $0.50 | $0.63 | $0.64 | $0.69 | $0.72 | $0.74 |
| Low | $0.41 | $0.47 | $0.62 | $0.63 | $0.68 | $0.71 | $0.73 |
| High | $0.49 | $0.51 | $0.64 | $0.66 | $0.70 | $0.74 | $0.76 |
| Analysts (Rev / EPS) | 4 / 5 | 4 / 4 | 3 / 2 | 3 / 2 | 2 / 1 | 2 / 1 | 3 / 2 |